Glu-Urea-Lys Scaffold Functionalized Superparamagnetic Iron Oxide Nanoparticles Targeting PSMA for In Vivo Molecular MRI of Prostate Cancer

The prostate specific membrane antigen (PSMA), extensively overexpressed on prostate cancer (PCa) cell surface, has been validated as a diagnostic biomarker for PCa. However, insufficient attention has been paid to the development of PSMA-specific probes loaded with small chemical molecules for the...

Full description

Bibliographic Details
Main Authors: Wei Zhou, Jiandong Huang, Qingwei Xiao, Shunmin Hu, Shijia Li, Jie Zheng, Zhiyun Du, Jiangling Peng, Huixiong Chen
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/10/2051
_version_ 1827648309784739840
author Wei Zhou
Jiandong Huang
Qingwei Xiao
Shunmin Hu
Shijia Li
Jie Zheng
Zhiyun Du
Jiangling Peng
Huixiong Chen
author_facet Wei Zhou
Jiandong Huang
Qingwei Xiao
Shunmin Hu
Shijia Li
Jie Zheng
Zhiyun Du
Jiangling Peng
Huixiong Chen
author_sort Wei Zhou
collection DOAJ
description The prostate specific membrane antigen (PSMA), extensively overexpressed on prostate cancer (PCa) cell surface, has been validated as a diagnostic biomarker for PCa. However, insufficient attention has been paid to the development of PSMA-specific probes loaded with small chemical molecules for the in vivo molecular imaging of PCa. In this study, we innovatively labelled superparamagnetic iron oxide nanoparticles with a PSMA-targeting Glu-Urea-Lys scaffold. An optimized synthetic route was developed to offer a physiochemically stable probe. The probe demonstrated high binding affinity (0.38 ± 0.08 μg(Fe)/mL) and binding specificity to PSMA expressed on prostate cancer cell surface in vitro. In a xenograft PCa mouse model, significant negative contrast of the implanted prostate cancer xenograft could be specifically observed by MRI 6 h after tail vein injection of the tracer (Fe, 20 mg/kg), exhibiting its potential to exclusively enhance magnetic resonance detection of PCa.
first_indexed 2024-03-09T19:35:30Z
format Article
id doaj.art-547e953dcb814b4b99342e108444dd16
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T19:35:30Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-547e953dcb814b4b99342e108444dd162023-11-24T01:54:45ZengMDPI AGPharmaceutics1999-49232022-09-011410205110.3390/pharmaceutics14102051Glu-Urea-Lys Scaffold Functionalized Superparamagnetic Iron Oxide Nanoparticles Targeting PSMA for In Vivo Molecular MRI of Prostate CancerWei Zhou0Jiandong Huang1Qingwei Xiao2Shunmin Hu3Shijia Li4Jie Zheng5Zhiyun Du6Jiangling Peng7Huixiong Chen8School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, 100 Waihuanxi Road, Guangzhou 510006, ChinaSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, 100 Waihuanxi Road, Guangzhou 510006, ChinaSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, 100 Waihuanxi Road, Guangzhou 510006, ChinaSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, 100 Waihuanxi Road, Guangzhou 510006, ChinaSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, 100 Waihuanxi Road, Guangzhou 510006, ChinaSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, 100 Waihuanxi Road, Guangzhou 510006, ChinaSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, 100 Waihuanxi Road, Guangzhou 510006, ChinaSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, 100 Waihuanxi Road, Guangzhou 510006, ChinaSchool of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, 100 Waihuanxi Road, Guangzhou 510006, ChinaThe prostate specific membrane antigen (PSMA), extensively overexpressed on prostate cancer (PCa) cell surface, has been validated as a diagnostic biomarker for PCa. However, insufficient attention has been paid to the development of PSMA-specific probes loaded with small chemical molecules for the in vivo molecular imaging of PCa. In this study, we innovatively labelled superparamagnetic iron oxide nanoparticles with a PSMA-targeting Glu-Urea-Lys scaffold. An optimized synthetic route was developed to offer a physiochemically stable probe. The probe demonstrated high binding affinity (0.38 ± 0.08 μg(Fe)/mL) and binding specificity to PSMA expressed on prostate cancer cell surface in vitro. In a xenograft PCa mouse model, significant negative contrast of the implanted prostate cancer xenograft could be specifically observed by MRI 6 h after tail vein injection of the tracer (Fe, 20 mg/kg), exhibiting its potential to exclusively enhance magnetic resonance detection of PCa.https://www.mdpi.com/1999-4923/14/10/2051prostate cancerPSMAmolecular imagingMRI contrast agentSPIONs
spellingShingle Wei Zhou
Jiandong Huang
Qingwei Xiao
Shunmin Hu
Shijia Li
Jie Zheng
Zhiyun Du
Jiangling Peng
Huixiong Chen
Glu-Urea-Lys Scaffold Functionalized Superparamagnetic Iron Oxide Nanoparticles Targeting PSMA for In Vivo Molecular MRI of Prostate Cancer
Pharmaceutics
prostate cancer
PSMA
molecular imaging
MRI contrast agent
SPIONs
title Glu-Urea-Lys Scaffold Functionalized Superparamagnetic Iron Oxide Nanoparticles Targeting PSMA for In Vivo Molecular MRI of Prostate Cancer
title_full Glu-Urea-Lys Scaffold Functionalized Superparamagnetic Iron Oxide Nanoparticles Targeting PSMA for In Vivo Molecular MRI of Prostate Cancer
title_fullStr Glu-Urea-Lys Scaffold Functionalized Superparamagnetic Iron Oxide Nanoparticles Targeting PSMA for In Vivo Molecular MRI of Prostate Cancer
title_full_unstemmed Glu-Urea-Lys Scaffold Functionalized Superparamagnetic Iron Oxide Nanoparticles Targeting PSMA for In Vivo Molecular MRI of Prostate Cancer
title_short Glu-Urea-Lys Scaffold Functionalized Superparamagnetic Iron Oxide Nanoparticles Targeting PSMA for In Vivo Molecular MRI of Prostate Cancer
title_sort glu urea lys scaffold functionalized superparamagnetic iron oxide nanoparticles targeting psma for in vivo molecular mri of prostate cancer
topic prostate cancer
PSMA
molecular imaging
MRI contrast agent
SPIONs
url https://www.mdpi.com/1999-4923/14/10/2051
work_keys_str_mv AT weizhou gluurealysscaffoldfunctionalizedsuperparamagneticironoxidenanoparticlestargetingpsmaforinvivomolecularmriofprostatecancer
AT jiandonghuang gluurealysscaffoldfunctionalizedsuperparamagneticironoxidenanoparticlestargetingpsmaforinvivomolecularmriofprostatecancer
AT qingweixiao gluurealysscaffoldfunctionalizedsuperparamagneticironoxidenanoparticlestargetingpsmaforinvivomolecularmriofprostatecancer
AT shunminhu gluurealysscaffoldfunctionalizedsuperparamagneticironoxidenanoparticlestargetingpsmaforinvivomolecularmriofprostatecancer
AT shijiali gluurealysscaffoldfunctionalizedsuperparamagneticironoxidenanoparticlestargetingpsmaforinvivomolecularmriofprostatecancer
AT jiezheng gluurealysscaffoldfunctionalizedsuperparamagneticironoxidenanoparticlestargetingpsmaforinvivomolecularmriofprostatecancer
AT zhiyundu gluurealysscaffoldfunctionalizedsuperparamagneticironoxidenanoparticlestargetingpsmaforinvivomolecularmriofprostatecancer
AT jianglingpeng gluurealysscaffoldfunctionalizedsuperparamagneticironoxidenanoparticlestargetingpsmaforinvivomolecularmriofprostatecancer
AT huixiongchen gluurealysscaffoldfunctionalizedsuperparamagneticironoxidenanoparticlestargetingpsmaforinvivomolecularmriofprostatecancer